Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-011498
Filing Date
2021-02-25
Accepted
2021-02-25 07:57:15
Documents
12
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea136471-6k_immuronltd.htm 6-K 12250
2 HALF YEARLY REPORT AND ACCOUNTS ea136471ex99-1_immuronltd.htm EX-99.1 461687
3 GRAPHIC image_001.jpg GRAPHIC 1395
4 GRAPHIC ex99-1_001.jpg GRAPHIC 166479
5 GRAPHIC ex99-1_002.jpg GRAPHIC 172838
6 GRAPHIC ex99-1_003.jpg GRAPHIC 5147
7 GRAPHIC ex99-1_004.jpg GRAPHIC 6805
8 GRAPHIC ex99-1_005.jpg GRAPHIC 4711
9 GRAPHIC ex99-1_007.jpg GRAPHIC 176922
10 GRAPHIC ex99-1_008.jpg GRAPHIC 196965
11 GRAPHIC ex99-1_006.jpg GRAPHIC 3284
12 GRAPHIC ex99-1_009.jpg GRAPHIC 175502
  Complete submission text file 0001213900-21-011498.txt   1729805
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 21676460
SIC: 2834 Pharmaceutical Preparations